Investing Profile

Daniela Begolo

InvestorVC
Principal at Inkef
eqtgroup.com/about/people/dan...Amsterdam, Netherlands
Photo of Daniela Begolo, Principal at INKEF Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
M Ventures Network
23 CONNECTIONS
Inkef Network
14 CONNECTIONS
Inkef Network
14 CONNECTIONS
cb
INKEF Capital Principal
$11.0M - $65.0M
$25.0M
3
€500M
CompanyStageDateRound SizeTotal Raised
Kinaset Therapeutics
Series BJan 2026$100M
$140M
Co-investors: Jamil Beg (5am Ventures)
Splice Bio
Series BJun 2025$140M
$190M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Joël Jean-Mairet (Ysios Capital), Beat Steffen (Novartis Venture Fund), Laia Crespo (Sanofi Ventures), Carole Nuechterlein (F.Hoffmann-La Roche), Sylvain Sachot (Asabys Partners)
Mosanna Therapeutics
Series AJun 2025$80M
$80M
Co-investors: Jennifer Lee (Pivotal bioVenture Partners), Brian Matesic (Norwest Venture Partners)
Early Stage Researcher, Marie Skłodowska-Curie Actions fellow HotmailPresent
Postoctoral Researcher HotmailPresent
Analyst M VenturesPresent
Associate InkefPresent
Senior Associate InkefPresent
Principal Inkef2022 - 2022
Università degli Studi di Padova Bachelor's degree Biotechnology
Università degli Studi di Padova Master's degree Industrial biotechnologies
Ruprecht-Karls-Universität Heidelberg Doctor of Philosophy - PhD Drug mode of action studies, Parasitology, Molecular Biology
Heidelberg University Doctor of Philosophy - PhD Drug mode of action studies, Parasitology, Molecular Biology